目錄:杭州斯達(dá)特生物科技有限公司>>蛋白>>藥物靶點(diǎn)和Fc受體>> UA010929OX40/TNFRSF4/CD134 Fc Chimera Protein, Rat
參考價(jià) | ¥ 1280 |
參考價(jià) | ¥ 1280 |
更新時(shí)間:2025-06-17 10:09:00瀏覽次數(shù):7評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,謝謝!
OX40, a member of the tumor necrosis factor receptor superfamily, is selectively expressed on activated T-cells. The engagement of OX40 during interactions between T-cells and dendritic cells is essential for the clonal expansion of antigen-specific T-cells and the establishment of T-cell memory. Recent animal model studies have highlighted the significant role of OX40 in the development of immunologic abnormalities, including inflammatory, autoimmune, infectious, allergic, and allotransplantation-related diseases. Inhibition of the OX40-OX40L interaction has demonstrated potential in preventing, curing, or alleviating these conditions. Conversely, OX40 activation can disrupt tolerance in cancer, reactivating antitumor immunity. These insights underscore the OX40/OX40L system as a promising target for immunotherapeutic interventions in the treatment of these diseases.
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)